Ad silico is redefining medical device innovation by using in silico trials and virtual patient populations to assess device safety and performance before human testing
Ad silico is redefining medical device innovation by using in silico trials and virtual patient populations to assess device safety and performance before human testing. Their generative AI technology creates customizable virtual models of human anatomy and physiology, allowing for faster and more efficient medical device development while reducing costs and patient harm.